Rie Makuuchi

Rie Makuuchi

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
TITomoyuki Irino
Tomoyuki Irino
MOManabu Ohashi
Manabu Ohashi
MHMasaru Hayami
Masaru Hayami
RMRie Makuuchi
Rie Makuuchi
MRMotonari Ri
Motonari Ri
SNSouya Nunobe
Souya Nunobe
Irino T, et al. J Gastric Cancer. 2025 Jan;25:e12. https://doi.org/10.5230/jgc.2025.25.e12

1 January 2023 in Journal of Gastric Cancer
Verified
Journal Article
Open access
MTMasayoshi Terayama
Masayoshi Terayama
MOManabu Ohashi
Manabu Ohashi
SISatoshi Ida
Satoshi Ida
MHMasaru Hayami
Masaru Hayami
RMRie Makuuchi
Rie Makuuchi
SNSouya Nunobe
Souya Nunobe
Terayama M, et al. J Gastric Cancer. 2023 Jan;23:e9. https://doi.org/10.5230/jgc.2023.23.e9

1 January 2024 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
MRMotonari Ri
Motonari Ri
MOManabu Ohashi
Manabu Ohashi
RMRie Makuuchi
Rie Makuuchi
MHMasaru Hayami
Masaru Hayami
TSTakeshi Sano
Takeshi Sano
SNSouya Nunobe
Souya Nunobe
Ri M, et al. J Gastric Cancer. 2024 Apr;24(2):220-230. https://doi.org/10.5230/jgc.2024.24.e17

1 January 2021 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
MRMotonari Ri
Motonari Ri
SNSouya Nunobe
Souya Nunobe
SISatoshi Ida
Satoshi Ida
NINaoki Ishizuka
Naoki Ishizuka
SAShinichiro Atsumi
Shinichiro Atsumi
TSTakeshi Sano
Takeshi Sano
Ri M, et al. J Gastric Cancer. 2021 Nov;21:e31. https://doi.org/10.5230/jgc.2021.21.e31

11 January 2022 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
IYItaru Yasufuku
Itaru Yasufuku
MOManabu Ohashi
Manabu Ohashi
RMRie Makuuchi
Rie Makuuchi
MHMasaru Hayami
Masaru Hayami
SISatoshi Ida
Satoshi Ida
SNSouya Nunobe
Souya Nunobe

20 November 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Ryota MatsuiRyota Matsui
Ryota Matsui
SNSouya Nunobe
Souya Nunobe
MRMotonari Ri
Motonari Ri
RMRie Makuuchi
Rie Makuuchi
TITomoyuki Irino
Tomoyuki Irino
TSTakeshi Sano
Takeshi Sano
Background: This study aimed to determine whether the prealbumin prognostic score (PPS), a novel indicator using prealbumin instead of albumin in the modified Glasgow Prognostic Score (mGPS), is a better predictive marker postoperatively in patients with gastric cancer. Methods: This retrospective study included consecutive patients who underwent radical gastrectomy for primary pStages I–III gastric cancer between 2006 and 2017. The cutoff values for preoperative prealbumin and C-reactive protein (CRP) were 22 mg/dL and 0.5 mg/dL, respectively. According to the prealbumin and CRP levels, a PPS of zero was defined as both being above the cutoff value, of one as either being below the cutoff value, and of two as both being below the cutoff value. Results: Of the 4663 patients, 3421 (73.4%) had a score of zero, 984 (21.1%) had a score of one, and 258 (5.5%) had a score of two. The higher the PPS, the poorer the overall survival [OS] (p < 0.001). When comparing OS by the PPS in patients with an mGPS of zero, a PPS of one indicated poorer OS than a PPS of zero (p < 0.001). In the multivariate analysis, PPSs of one (hazard ratio [HR]: 1.603; 95% confidence interval [CI]: 1.378–1.866; p < 0.001) and two (HR: 1.322; 95% CI: 1.055–1.656; p = 0.015) were independent poor prognostic factors for OS. Conclusions: The PPS, which is based on a combination of prealbumin and CRP levels, can identify a wider range of patients with poor OS than mGPS in patients with gastric cancer after gastrectomy.